Cargando…
Mucormycosis and aspergillosis: The deadly duo in COVID-19—a case report
COVID-19 disease has been associated with fungal infections such as aspergillosis and mucormycosis, especially in diabetic patients who have suffered from a moderately severe form of COVID-19 infection and are treated with steroids. Though there are multiple case reports describing co-infection with...
Autores principales: | Mohanty, Bijaya, Ansari, Zeya, Prasad, Anil, Gupta, Minakshi, Kumar, Alok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810923/ https://www.ncbi.nlm.nih.gov/pubmed/36618238 http://dx.doi.org/10.4103/jfmpc.jfmpc_359_22 |
Ejemplares similares
-
The Deadly Duo of COVID-19 and Cancer!
por: Bora, Vivek R., et al.
Publicado: (2021) -
Pulmonary aspergillosis and mucormycosis in a patient with COVID-19
por: Johnson, Andre K., et al.
Publicado: (2021) -
Cold agglutinin-induced hemolytic anemia as the primary presentation in SLE - A case report
por: Mohanty, Bijaya, et al.
Publicado: (2019) -
Dexamethasone: Pulmonary aspergillosis and mucormycosis: case report
Publicado: (2021) -
COVID-19 associated with concomitant mucormycosis and aspergillosis
por: Lai, Chih-Cheng, et al.
Publicado: (2022)